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Abstract objective Reference intervals (RIs) currently being used in Ethiopia are derived from western
populations. Thus, this study aimed to establish locally derived haematological and immunological
RIs.
method The study was conducted in Amhara State, Ethiopia with a total of 967 (55.2% males)
participants. 56.9% of males and 43.1% of females were eligible for haematological and
immunological RI determination. A non-parametric test was used for the determination of upper
(97.5th percentile) and lower (2.5th percentile) reference interval limits with 95% CI. The Harris and
Boyd Rule was used to determine the need of partitioning of reference intervals based on gender.
result The established 95% reference intervals (2.5th–97.5th percentile) were: for WBC: 3–
11.2 9 109/l; for platelet: 90–399 9 109/l; for RBC: 4–6 9 1012/l for males and 3.5–5.6 9 1012/l for
females; for haemoglobin: (Hgb) 12–18.9 g/dl for males and 10.7–17.5 g/dl for females; for PCV:
35.7–55.3% for males and 32.2–50.1% for females; for CD4: 400–1430 9 109/l for males and 466–
1523 9 109/l for females; for CD4 percentage: 18–49.1% for males and 21.3–52.9% for females; for
MCV: 81–100 fl; for MCH: 25.3–34.6 pg; MCHC: 28.8–36.9%; for RDW: 11.6–15.4% and for
MPV: 8–12.3 fl. Males had significantly higher RBC, Hgb and PCV than females. CD4 counts and
CD4 percentage were significantly higher in females.
conclusion The reference intervals established in this study differ from others and thus should be
used for the interpretation of laboratory results in diagnosis and safety monitoring in clinical trials in
Amhara.
keywords reference interval, haematological parameter, immunological parameter, Amhara
Introduction
Reference intervals (RIs) are also popularly known as
reference ranges, normal values, normal ranges, biologi-
cal reference intervals and expected values [1]. In clini-
cal practice, before physiological assessments, medical
diagnosis and management decisions are made, patient’s
laboratory results are compared with the corresponding
reference intervals (RIs), which are bounded by a pair
of reference limits [1, 2]. RIs aid physicians in decision-
making in clinical medicine to interpret results, in evalu-
ating the state of health of individuals and populations,
in identifying people at risk for disease, in assessing
immune status, disease progression and treatment
responses [3]. They may also be used in clinical trials as
a guide to setting inclusion or exclusion criteria
and form the basis for safety monitoring of trial
participants [4].
Laboratory parameters vary considerably between
healthy people from different geographical locations,
mostly driven by ethnic, genetic, demographic, nutri-
tional, economic and environmental differences [5–10].
Moreover, they vary from laboratory to laboratory due
to differences among laboratories in clinical service needs,
analytic platforms, set criteria to define populations of
healthy individuals, analytic imprecisions made when RIs
were determined, differences in methods used to establish
RIs, techniques and timing of blood collection, subject’s
posture when the sample is taken, and physical activity
of individuals [11–13].
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Despite these differences, most African countries
including Ethiopia use western population-derived labora-
tory RIs for clinical diagnosis and research activities.
Studies conducted to evaluate and establish locally
derived RIs in several African countries [6, 7, 14–22]
revealed significant differences of locally derived RIs from
those of currently used western population-derived RIs.
This may lead to misclassification of patients that may
result in misdiagnoses, improper treatments or both.
Unless RIs are representative of the patient’s demograph-
ics and determined using similar pre-analytical procedures
and comparable analytical methods, they are inappropri-
ate as a diagnostic reference for clinical decision-making.
Several factors affect haematological and immunologi-
cal parameters. Therefore, the Clinical Laboratory Stan-
dards Institute/International Federation for Clinical
Chemistry (CLSI/IFCC) recommends that each laboratory
establish RIs from the local population [5, 10, 12].
Although some attempts have been made to determine
RIs in Ethiopia, they are fragmented and specific to small
groups [14, 15], not comprehensive enough to be used in
clinical practice [16, 22–24] and may lead to wrong
interpretation [25]. The RIs currently being used in
Ethiopia are derived from Caucasian populations.
Therefore, we aimed to establish locally derived RIs of
haematological and immunological parameters for adults
in the state of Amhara, Ethiopia. This the first study in
the country covering a large population.
Methods
Study setting and design
This was a cross-sectional study of 1040 blood donors in
the Amhara blood bank districts of Gondar, Bahirdar,
Debre Markos and Dessie to determine haematological
and immunological RIs. Amhara (9° to 13° 450 N and
36° to 40° 300E; 500–4620 m asl, 159 173.66 km2) com-
prises hot dry tropical, sub-tropical, temperate and alpine
climatic zones. In 2007, Amhara had a population of
17.2 million; 51.9% of the Ethiopian population were
aged 15–64 years and 45% were children <15 years [26].
Selection of reference population
We used a convenience sampling technique to select the
reference population during blood donation. Each blood
bank has a fixed blood collection centre and mobile
blood collection sites. The mobile blood collection teams
campaign in the community and collect blood from vol-
unteers. The objective of the study was explained to the
donors and informed consent taken. Volunteers’ general
good health was assessed through a medical history and
physical examination. Donors were screened for infec-
tious diseases by the Ethiopian blood bank service after
blood donation. We excluded individuals known to have
diabetes mellitus, chronic renal insufficiency, hyperten-
sion, ischemic heart disease, anaemia, thyroid or liver dis-
ease; those taking pharmacologically active substances or
any prescription drugs; smokers; individuals who had
malaria in the previous 3 months, individuals who had
jaundice or major surgery in the past year; pregnant
(determined clinically or by urine HCG test) and lactating
women; individuals who had donated blood in the previ-
ous 4 months and those who had received a blood trans-
fusion in the previous year. Serum blood samples were
screened for HIV, Hepatitis B virus, Hepatitis C virus
and syphilis using ELISA techniques at each blood bank
centre.
Laboratory analysis
Four ml of blood was collected from the antecubital vein
into a K3EDTA vacutainer tube for CD4 and complete
blood count. A three-part differential complete blood
count (CBC) was analysed using CELL-DYN 1800
(Abbott Laboratories Diagnostic Division, USA) at each
blood bank centre. We used diluent, detergent and CN-
free diff lyse CELL-DYN reagents supplied by Abbott
Laboratories Diagnostic Division. The analyser used elec-
trical impedance to count and size blood cells and the
methaemoglobin method for determination of Hgb, based
on the measurement of changes in electrical resistance
produced by cells suspended in conductive diluents as
they pass through an aperture of known dimensions. As
each cell passes through the aperture, a transitory change
in the resistance between the electrodes occurs, producing
a measurable electrical pulse. The number of pulses gen-
erated indicates the number of cells and the amplitude of
each pulse is proportional to cell volume. In this manner
cells are counted and classified into white blood cells
(WBC), red blood cells (RBC) and platelets. Haemoglobin
(Hgb), packed cell volume (PCV), absolute and relative
number of lymphocytes, neutrophils and mixed cells (ba-
sophils, monocytes, eosinophils), mean cell volume
(MCV), mean cell haemoglobin (MCH) and mean cell
haemoglobin concentration (MCHC) were analysed.
CD4 cell counts and CD4 percentages were determined
using a Becton Dickinson Fluorescence Activated Cell
Sorting (BD FACS) CountTM system (Becton Dickinson,
San Jose, CA, USA), which provides reproducible and
accurate results even with low CD4 counts and is widely
used for CD4 monitoring in HIV/AIDS treatment pro-
grams. BD FACS Count reagents are provided as
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complete kits that streamline CD4 counting. These kits
contain ready-to-use tubes with pre-measured antibodies
and beads for absolute counting, fixative solution, and
software that enables automated analysis without opera-
tor intervention. The beads and lymphocytes of interest
are automatically identified and absolute counts (cells/lL)
and percentages calculated. Quality controls in the soft-
ware detect and flag error conditions and suppress results
when control limits are exceeded.
Quality control
Protocols for sample collection, processing and trans-
portation were strictly followed to have safe procedures
and reliable specimens. Samples were analysed in
batches within 2 h of collection and delayed samples
were kept at 2–8 °C for a maximum of 12 h. During
analysis, both internal and external quality assurance
(QA) protocols were followed. As an internal QA, com-
mercial quality control samples were included in every
batch. Test samples were run if and only if quality con-
trol samples were within range. For haematology tests
three levels of whole blood controls (High, Medium,
and Low) and for CD4 cell count, two levels of whole
blood controls (Low, Normal) were used. All analytes
were analysed by following standard operational proce-
dures. As an external QA, the laboratory received qual-
ity control samples from the central laboratory,
analysed them as a patient sample and returned them to
the centre. The central laboratory then analysed the
data and gave performance evaluation feedback to each
laboratory. The central laboratory received QA materi-
als from UK and Canada.
Statistical analysis
Data were checked for completeness, cleaned, edited and
entered into Epi-Info version 3.5.1 and then transported
to SPSS v. 20 for statistical analysis. Outliers within each
subgroup were identified using the Dixon and Reed
method, namely the D/R ratio, where D is the absolute
difference between an extreme observation (large or
small) and the next largest (or smallest) observation, and
R is the range (maximum–minimum). Extreme values
were deleted from the distribution if D/R ≥ 1/3 [5]. RIs
were calculated according to the guideline of the Clinical
Laboratory Standards Institute/International Federation
for Clinical Chemistry (CLSI/IFCC) by employing a non-
parametric method to determine the median interquartile
ranges (IQR), combined or separate 95% RIs (2.5th and
97.5th percentiles). The 2.5th and 97.5th percentiles were
considered as lower and upper reference limits,
respectively, covering 95% of the reference interval of
each parameter [5]. RIs were determined separately for
males, females and combined genders. To determine com-
bined or separate gender RIs, the Harris and Boyd test
was used as described below [27, 28]:
Z ¼ Mean 1Mean 2
ðSD1=N1þ SD2=N2Þ1=2
where SD is standard deviation and N is the number of
samples of each gender. This statistical Z result was com-
pared with a critical Z* value:
Z ¼ 3½ðN1þN2Þ=2401=2
Separate RI was determined when Z > Z*. Based on
this test, separate- gender RIs were determined for RBC,
Hgb, PCV, CD4 and CD4 percentages (Table 1).
Ethics
This study was approved by the Research Review Board
of University of Gondar and permission was obtained
Table 1 Result of Harris and Boyd test, which was performed
to see the need for partitioning of reference interval based on
gender
Parameters
Harris and
Boyd
DecisionZ* Z
WBC (9109/L) 6.0 0.7 No separate RI
Neutrophil (9109/L) 6.0 1.1 No separate RI
Lymphocyte (9109/L) 6.0 0.1 No separate RI
Mixed cells (9109/L) 6.0 0.6 No separate RI
Neutrophil (%) 6.0 1.2 No separate RI
Lymphocyte (%) 6.0 0.3 No separate RI
Mixed cells % 6.0 2.0 No separate RI
Platelet (9109/l) 6.0 3.3 No separate RI
RBC (91012/l)** 6.0 18.6 Separate RI
Hgb (g/dl)** 6.0 16.7 Separate RI
PCV (%)** 6.0 19 Separate RI
MCH (pg) 6.0 1.3 No separate RI
MCHC (g/dl) 6.0 0.6 No separate RI
MCV (fl) 6.0 1.7 No separate RI
RDWCV 6.0 3.4 No separate RI
MPV 6.0 1 No separate RI
CD4 (9109/l)** 5.4 6.2 Separate RI
CD4 percentage** 5.4 6.7 Separate RI
Z*, critical value, Z, calculated value, Separate RI are needed
only when Z is greater than Z*; **Indicate haematological and
CD4 parameters which need partition between male and female
(Z > Z*).
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from the blood banks. Written informed consent was
obtained from each participant. The study participants
were informed about the aim of the study and its proce-
dure, and inclusion was voluntary. Confidentiality was
kept and withdrawal was possible at any stage.
Results
We enrolled 1040 volunteer blood donors aged 18–
61 years. 55.4% were male and 44.6% female. Of the
total, 967 (55.2% males and 44.8% females) were eligi-
ble for haematological RI determination and 784 (56.9%
males and 43.1% females) were eligible for immunologi-
cal RI determination. The median age of study partici-
pants was 20 years with an IQR of 5 years. 80% were
students aged 18–25 years.
The median and 95% reference intervals (2.5–97.5th
percentiles) for haematological and immunological
parameters are shown in Table 2. The combined median
and 95th percentile for both gender s were as follows:
6.1 (3–11.2 9 109/l) for WBC, 3.2 (1.1–6.7 9 109/l) for
absolute neutrophils, 2.1 (1.1–4.5 9 109/l) for absolute
lymphocytes, 0.7 (0.2–2.1 9 109/l) for absolute mixed
cells, 239 (90–399 9 109/L) for platelet, 90.1 (81–100 fl)
for MCV, 30 (25.3–34.6 pg) for MCH, 33.9 (28.8–
36.9%) for MCHC, 13.2 (11.6–15.4%) for RDW and 10
(8–12.3 fl) for MPV for both genders.
The separate RIs for males were 5.1 (4–6 9 1012/l) for
RBC, 15.3 (12–18.9 g/dl) for Hgb, 46.2 (35.7–55.3%)
for PCV, 721 (400–1430 9 109/l) for CD4 and 36.3 (18–
49.1%) for CD4 percentage. RIs for females were 4.5
(3.5–5.6 9 1012/l) for RBC, 13.1 (10.7–17.5 g/dl) for
Hgb, 39.9 (32.2–50.1%) for PCV, 830 (466–
1523 9 109/L) for CD4 and 40.3 (21.3–52.9%) for CD4
percentage. Males had significantly higher RBC, Hgb and
PCV than females, whereas CD4 counts and CD4 per-
centages were significantly higher in females. The distri-
bution of these variations with gender are expressed in
Box and Whisker plots (Figure 1).
Discussion
Local RIs are recommended to be established and used
for interpretation of laboratory results during screening,
Table 2 Median, IQR, and 95th percentile of reference interval with lower and upper limit 95% CI of haematological and immuno-
logical parameters
Parameter N Median (IQR) RI (95th percentile) Lower limit 95% CI Upper limit 95% CI
WBC (9109/l) 967 6.1 (4.8–7.7) 3–11.2 3 (2.7–3.1) 11.2 (10.8–11.9)
Neutrophil (9109/l) 967 3.2 (2.2–4.2) 1.1–6.7 1.1 (0.9–1.2) 6.7 (6.5–6.9
Lymphocyte (9109/l) 967 2.1 (1.7–2.6) 1.1–4.5 1.1 (1–1.2) 4.5 (4.2–4.7)
Mixed cells (9109/l) 967 0.7 (0.5–1) 0.2–2.1 0.2 (0.2–0.3) 2.1 (2–2.1)
Neutrophil % 967 52 (43.5–59.4) 27.2–71.9 27.2 (25.4–29.9) 71.9 (69.6–73.1)
Lymphocyte % 967 35.4 (29.4–42.1) 19.8–57.4 19.8 (18.8–20.9) 57.4 (56–58.1)
Mixed cells % 967 11.3 (8.9–15.2) 5.2–26.4 5.2 (4.5–5.6) 26.4 (25.2–28
PLT (9109/l) 967 239 (186–293) 90–399 90 (84–94) 399 (381–417)
RBC (91012/l)
Male 534 5.1 (4.8–5.5) 4.0–6.0 4 (3.9–4.2) 6 (6–6.2)
Female 433 4.5 (4.2–4.8) 3.5–5.6 3.5 (3.4–3.6) 5.6 (5.4–5.9)
Hgb (g/dl)
Male 534 15.3 (14.2–16.5) 12–18.9 12 (11.6–12.2) 18.9 (18.5–19.3)
Female 433 13.1 (12.1–14.3) 10.7–17.5 10.7 (10.5–11) 17.5 (17–18.3)
PCV (%)
Male 534 46.2 (43.6–49.2) 35.7–55.3 35.7 (34.8–36.9) 55.3 (54.2–56)
Female 433 39.9 (37.6–43.5) 32.2–50.1 32.2 (31–33) 50.1 (48.5–52.4)
MCV (fl) 967 90.1 (87–93) 81–100 81 (80.4–82) 99.7 (98.7–100.7)
MCH (pg) 967 30 (28.1–31.7) 25.3–34.6 25.3 (25.1–25.7) 34.5 (34.3–35.2)
MCHC (%) 967 33.9 (30.5–35.1) 28.8–36.9 28.8 (28.5–29) 36.9 (36.6–37.1)
RDW (%) 967 13.2 (12.7–13.8) 11.6–15.4 11.6 (11.4–11.8) 15.4 (15.2–15.7)
MPV (fl) 967 10 (9.3–10.6) 8–12.3 8 (7.9–8.2) 12.3 (12–12.4)
CD4 (9109/l)
Male 446 715 (592–874) 400–1406 400 (370–431) 1406 (1250–1477)
Female 338 830 (677–1017) 466–1523 465 (388–494) 1523 (1412–1621)
CD4%
Male 446 36.3 (31.8–40.7) 18–49.1 18 (15.7–20.6) 49.1 (47.9–49.9)
Female 338 40.3 (34.6–44.7) 21.3–52.9 21.3 (15.9–25.6) 52.9 (51.1–55.4)
768 © 2018 John Wiley & Sons Ltd
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diagnosis and monitoring of patients and to assure the
health status of individuals involved in clinical trials [4–
6, 12]. The RIs derived in this study varied from those
reported in other areas [6, 14, 15, 29–31] and in text
books [12, 32–34], as would be expected for populations
in other geographical locations, with genetic and dietary
diversities [5]. As indicated in Table 3, the lower RI limit
of total WBC count in this study was lower than previ-
ously reported from different parts of Ethiopia [14, 15],
Eastern and Southern Africa [6], Western Kenya [7],
Ghana [29], USA [30] and Caucasian populations [12,
32, 33]; but it was higher than in Kericho district of
Kenya [31], Togo [35] and Uganda [4]. The WBC RI for
this study is in agreement with southern Tanzania’s [36]
RI lower limit, whereas our upper RI limit was lower
than in Gojjam district of Ethiopia [15], in books [32,
33] but higher than reported from Africa [4, 6, 7, 14, 31,
35], USA [30] and in text books [12, 34]. Similarly the
absolute neutrophil and lymphocyte count RI upper lim-
its are higher than in most African countries RIs [4, 6, 7,
14, 31, 35] but lower than in Caucasian populations [12,
30, 34]. These variations are usually associated with
well-known differences in altitude, environment, diet and
ethnic background [5]. There was no significant differ-
ence in WBC count between males and females, confirm-
ing results of other studies [6, 14, 15, 29–31].
The 95th percentile RIs of our lower limit RI of RBC
in both genders were lower than those in Kenya [7, 31],
Tanzania [36], USA [30] and western text books [32, 34]
and higher than in previous studies in Gondar, Ethiopia
[14], Ghana [29], Togo [35] and Uganda [4]. The upper
limit RI was lower than previous studies in Ethiopia [14,
15], Togo [35] but higher than in Ghana [29], USA [30]
and in western books [32, 34]. The differences might be
due to geographical variation (altitude), environment,
diet, ethnic background, method and instrument used for
analysis (CLSI) [5, 17].
The lower limit of Hgb and PCV RIs in this study was
lower than in Gojjam [15], Tanzania [36] and the USA
[30], but higher than in Eastern and Western Africa [6],
Ghana [29], Western Kenya [7], Togo [35] and Uganda
[4] for both genders. The upper limit of Hgb was higher
than in Eastern and Western Africa [6], Ghana [29],
Kenya [7, 31], Togo [35], Uganda [4], USA [30] but
lower than in Gojjam [15], probably due to altitude and
ethnic variations [5, 37, 38]. Thus, it may not be possible
to even have one standard reference between two locali-
ties in the same county, as seen in Ethiopia and Kenya
[7, 14, 15, 31].
The reference intervals of MCV, MCH and MCHC in
this study varied from those of other studies (Table 3).
Generally, the RI of MCV is higher than in other African
7.00 22.00
60.00
50.00
40.00
30.00
20.00
18.00
16.00H
gb
PC
V
14.00
12.00
10.00
6.00
5.00
R
BC
4.00
3.00
2000.00 60.00
50.00
40.00
30.00
CD
4 
pe
rc
en
ta
ge
20.00
10.00
1500.00
1000.00CD
4
500.00
.00
Male
Sex
Female
Male
Sex
Female Male
Sex
Female
Male
Sex
Female Male
Sex
Female
(a) (b) (c)
(d) (e)
Figure 1 Box and whisker plots indicating the effect of gender on haematological and immunological parameters of the study partici-
pants. (a) Red blood cells, (b) Haemoglobin, (c) Packed cell volume, (d) CD4 counts and (e) CD4%.
© 2018 John Wiley & Sons Ltd 769
Tropical Medicine and International Health volume 23 no 7 pp 765–773 july 2018
B. Enawgaw et al. Reference intervals in Amhara, Ethiopia
T
a
b
le
3
C
o
m
p
a
ri
so
n
o
f
h
a
em
a
to
lo
gi
ca
l
R
Is
o
f
th
e
cu
rr
en
t
st
u
d
y
w
it
h
p
re
vi
o
u
s
st
u
d
ie
s
in
A
fr
ic
a
,
U
S
A
a
n
d
te
st
b
o
o
k
s
P
a
ra
m
et
er
s
C
u
rr
en
t
S
tu
d
y
G
o
n
d
a
r,
E
th
io
p
ia
[1
4
]
G
o
jj
a
m
,
E
th
io
p
ia
[1
5
]
K
er
ic
h
o
,
K
en
y
a
[3
1
]
E
a
st
er
n
&
S
o
u
th
er
n
A
fr
ic
a
[6
]
G
h
a
n
a
[2
9
]
S
o
u
th
er
n
T
a
n
za
n
ia
[3
6
]
U
g
a
n
d
a
[4
]
T
o
g
o
[3
5
]
U
S
A
[3
0
]
R
o
d
a
k
’s
H
a
em
a
to
lo
g
y
[3
4
]
W
B
C
(9
1
0
9
/l
)
3
–1
1
.2
3
.2
–8
.8
3
.5
–1
1
.5
2
.8
–8
.2
3
.1
–9
.1
3
.4
–9
.2
3
–7
.9
2
.8
–8
.2
1
.9
–1
0
.1
4
.5
–1
1
3
.6
–1
0
.6
N
eu
tr
o
p
h
il
(9
1
0
9
/l
)
1
.1
–6
.7
1
.6
–5
.1
N
A
0
.9
–4
.7
1
.0
–5
.3
1
.5
–5
.6
1
.1
–4
.7
0
.9
–3
.9
0
.5
–5
.4
N
A
1
.7
–7
.5
L
y
m
p
h
o
cy
te
(9
1
0
9
/l
)
1
.1
–4
.5
1
–3
.5
N
A
1
.1
–3
.5
1
.2
–3
.5
1
.2
–4
.4
1
.1
–3
1
.2
–3
.7
1
.1
–4
.3
N
A
1
–3
.2
M
ix
ed
ce
ll
s
(9
1
0
9
/l
)
0
.2
–2
.1
0
.2
–1
N
A
N
A
N
A
N
A
0
.3
–1
.1
N
A
N
A
N
A
N
A
N
eu
tr
o
p
h
il
%
2
7
.2
–7
1
.9
3
6
–6
9
3
4
.3
–7
2
.1
2
0
–6
0
2
5
–6
6
3
2
–6
8
.1
3
2
–6
9
.1
2
2
.2
–5
9
.3
N
A
4
0
–7
0
5
0
–7
0
L
y
m
p
h
o
cy
te
%
1
9
.8
–5
7
.4
2
2
–5
5
1
7
.9
–5
3
.4
2
0
–6
0
2
3
–5
9
2
5
.2
–5
7
.7
2
0
.8
–5
6
.7
2
6
.7
–6
1
.2
N
A
2
2
–4
4
1
8
–4
2
M
ix
ed
ce
ll
s
%
5
.2
–2
6
.4
6
–1
3
6
–2
3
N
A
N
A
N
A
5
.6
–1
9
.8
N
A
N
A
N
A
P
L
T
(9
1
0
9
/l
)
9
0
–3
9
9
1
2
8
–4
3
2
1
1
3
.9
–3
7
2
1
2
0
–4
1
1
1
2
6
–4
3
8
8
9
–3
8
0
1
5
0
–3
9
5
1
0
9
–3
8
4
1
2
0
–4
4
3
1
5
0
–3
5
0
1
5
0
–4
5
0
R
B
C
(9
1
0
1
2
/l
)
M
4
.0
–6
.0
3
.5
3
–6
.9
3
3
.9
–6
.2
4
–6
.4
4
.4
–6
.3
3
.7
9
–5
.9
6
4
.4
1
–6
.2
7
3
.8
–6
.1
3
.3
–6
.4
4
.5
–5
.9
4
.2
–6
F
3
.5
–5
.6
3
.4
5
–6
.2
5
3
.9
–5
.8
3
.8
–5
.6
3
.7
–5
.6
3
.0
9
–5
.3
0
3
.8
4
–5
.5
9
3
.3
–5
.3
3
.1
–6
4
–5
.2
3
.8
-5
.2
H
g
b
(g
/d
l)
M
1
2
–1
8
.9
1
1
.5
–1
8
1
3
.6
–1
9
.8
1
2
.2
–1
7
.7
8
.3
–1
1
.3
1
1
.3
–1
6
.4
1
3
.7
–1
7
.7
1
1
.6
–1
7
.1
1
0
–1
8
.4
1
3
.5
–1
7
.5
1
3
.5
–1
8
F
1
0
.7
–1
7
.5
1
0
.9
–1
6
.9
1
2
–1
8
9
.5
–1
5
.8
5
.9
–1
0
8
8
–1
4
4
1
1
.1
–1
5
.7
9
.8
–1
6
.2
1
0
.3
–1
7
.1
1
2
–1
6
1
2
–1
5
P
C
V
(%
)
M
3
5
.7
–5
5
.3
3
6
.2
–5
8
.6
4
5
–5
9
3
5
– 5
0
.8
4
0
–5
0
3
3
.2
–5
0
.5
4
0
.2
–5
3
.7
3
3
.8
–4
9
.5
2
8
–5
4
4
1
–5
3
4
0
–5
4
F
3
2
.2
–5
0
.1
3
2
.1
–5
6
.6
3
9
–5
5
9
.4
–4
5
.4
3
0
–5
0
2
6
.4
–4
5
.0
3
6
.2
–4
6
.8
2
8
.3
–4
6
.8
2
8
–4
7
3
6
–4
6
3
5
–4
9
M
C
V
(fl
)
8
1
–1
0
0
8
5
–1
0
0
8
9
.5
–1
0
7
.5
6
8
.8
–9
7
.2
6
8
–9
8
7
2
–9
7
7
7
.6
–9
8
.1
7
1
–9
7
8
0
–9
9
8
0
–1
0
0
8
0
–1
0
0
M
C
H
(p
g
)
2
5
.3
–3
4
.6
N
A
2
8
–3
4
2
2
.4
–3
3
.5
N
A
2
2
.6
–3
3
.5
2
3
.6
–3
3
.1
2
3
.5
–3
3
.7
2
5
–3
7
2
6
–3
4
2
6
–3
4
M
C
H
C
(%
)
2
8
.8
–3
6
.9
N
A
3
0
–3
3
.2
3
2
.2
–3
5
.3
N
A
3
0
.5
–3
6
.2
3
0
.6
–3
4
.9
3
2
.5
–3
5
.3
2
9
–4
1
3
1
–3
7
3
2
–3
6
R
D
W
(%
)
1
1
.6
– 1
5
.4
1
2
–1
8
N
A
N
A
N
A
1
2
.6
–2
3
N
A
1
1
–1
6
.8
N
A
1
1
.5
–1
4
.5
1
1
.5
–1
4
.5
M
P
V
(fl
)
8
–1
2
.3
N
A
N
A
N
A
N
A
N
A
N
A
N
A
N
A
N
A
7
–1
2
N
.B
:
N
A
;
n
o
t
a
p
p
li
ca
b
le
(t
h
er
e
is
n
o
v
a
lu
e)
.
770 © 2018 John Wiley & Sons Ltd
Tropical Medicine and International Health volume 23 no 7 pp 765–773 july 2018
B. Enawgaw et al. Reference intervals in Amhara, Ethiopia
countries [4, 6, 7, 29, 31, 36] and comparable with
Togo [35], USA [30] and values in text books [34].
MCH and MCHC values showed variable results and
RDW RIs are comparable with other studies [30, 34].
We observed a significant gender difference on red cell
parameters (RBC, Hgb and PCV). Higher values were
seen in males than females, confirming previous findings
[12, 32–34] in Ethiopia [14, 15], Eastern and South
Africa [6], Ghana [29], Kenya [7, 31], South Tanzania
[36], Togo [35], Uganda [4] and USA [30]. The signifi-
cant differences between men and women in RBC, Hgb
and PCV may be due to biological and physiological
factors, such as the influence of androgen hormone on
erythropoiesis [39] and menstrual blood loss in females
[40].
The RIs of platelets in this study were lower than in
Gondar [14], Eastern and Southern Africa [6], Kenya
[7, 31], Togo [35] and Caucasian populations [32, 34].
However, the RI values are higher than Ghana [29].
This is may be associated with high altitude in Ethiopia,
as platelet count decreases and mean platelet volume
(MPV) increases with altitude [41–43] (Table 4).
CD4 RI determination is also important because CD4
lymphocyte cells are used for assessment of immune sta-
tus, disease progression and treatment responses of
patients, especially individuals living with HIV [3, 44].
CD4 cell counts were higher than in Addis Ababa [16],
Tanzania [21] and Central African Republic [20]; but
lower than in Gojjam, Ethiopia [15], Gauteng, South
Africa [45] and Turkey [46]. CD4 percentages RI in this
study were generally lower than in other countries
[7, 16, 45, 46], possibly due to ethnic and environmen-
tal factors [47, 48]. There was a significant gender dif-
ference in absolute CD4 cells and CD4 percentages. The
higher values seen in women in our study are consistent
with other studies [7, 15, 16, 19, 20, 45] and may be
due to the effect of sex hormones [49].
One limitation of our study is that the majority of the
reference population included were young adults. Sec-
ondly, we did not screen the reference population for
infectious diseases such as intestinal parasites.
Conclusion
The reference values we established for the state of
Amhara, Ethiopia will be helpful for the screening, diag-
nosis, monitoring and follow-up of patients. This study
provides the first haematological and immunological RIs
for a larger population in the state of Amhara, Ethiopia,
and is the largest in the country. The RIs generated in
Amhara differ from others in Africa and western coun-
tries. The WBC RI showed a wider range, with lower T
a
b
le
4
C
o
m
p
a
ri
so
n
o
f
C
D
4
a
n
d
C
D
4
%
R
Is
o
f
th
e
cu
rr
en
t
st
u
d
y
w
it
h
p
re
vi
o
u
s
st
u
d
ie
s
in
E
th
io
p
ia
,
o
th
er
A
fr
ic
a
n
co
u
n
tr
ie
s
a
n
d
T
u
rk
ey
P
a
ra
m
et
er
s
C
u
rr
en
t
S
tu
d
y
G
o
jj
a
m
,
E
th
io
p
ia
[1
5
]
A
d
d
is
A
b
a
b
a
,
E
th
io
p
ia
[1
6
]
W
es
te
rn
K
en
y
a
[7
]
C
en
tr
a
l
A
fr
ic
a
n
R
ep
u
b
li
c
[2
0
]
N
o
rt
h
er
n
T
a
n
za
n
ia
[2
1
]
U
g
a
n
d
a
[1
9
]
G
a
u
te
n
g
,
S
o
u
th
A
fr
ic
a
[4
5
]
T
u
rk
ey
[4
6
]
C
D
4
(9
1
0
9
/L
)
M
4
0
0
–1
4
3
0
4
1
4
–1
4
7
4
3
0
6
–1
2
4
9
4
6
2
–1
3
0
6
3
9
1
–1
1
4
5
3
6
2
–1
3
7
6
5
0
3
–1
8
0
7
2
9
1
.2
–1
2
7
8
.9
4
3
8
–1
8
9
0
F
4
6
6
–1
5
2
3
4
3
6
–1
6
9
5
4
5
6
–1
3
6
8
4
4
0
–1
6
0
2
3
8
6
–1
3
5
5
4
5
4
–1
4
8
5
5
6
1
–2
0
5
1
2
8
8
.5
–1
4
0
6
.8
3
9
4
–2
2
3
4
C
D
4
%
M
1
8
–4
9
.1
N
A
N
A
3
2
–5
5
2
3
–5
4
1
6
.5
–4
5
.3
2
7
.7
–5
6
.7
N
A
2
9
.9
1
–6
0
.1
2
F
2
1
.3
–5
2
.9
N
A
N
A
2
9
–5
4
2
9
–5
5
2
2
.5
–4
8
.3
3
1
.6
–5
8
.0
N
A
2
9
.7
4
–6
1
.4
1
© 2018 John Wiley & Sons Ltd 771
Tropical Medicine and International Health volume 23 no 7 pp 765–773 july 2018
B. Enawgaw et al. Reference intervals in Amhara, Ethiopia
and upper RI limits showing variations from previous
studies. Similarly, RBC parameters (RBC, Hgb and PCV),
showed a slightly higher upper RI limit, whereas platelet
counts, absolute CD4 counts and CD4 percentages gave
lower RIs in this study. Thus the use of western RIs
could lead to wrong diagnosis and interpretation of labo-
ratory results. It is also advisable to establish RIs for the
younger and older populations, giving due consideration
to the effect of infectious diseases on haematological and
immunological parameters.
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